Arkolith/Insider Trading/APLT/Form 4

Shendelman Shoshana

President and CEO, Director, 10% OwnerApplied Therapeutics, Inc. (APLT) · full profile →Form 4 · filed Mar 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2024Sell(S)319K$5.39$1.7M3.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001096906-24-000497) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML